March 8, 2013 - Breaking News!
Biomatter accepted for indexing in Medline!
Biomatter Volume 3, Issue 1 includes a Special Focus on "Delivery, Retention and Engraftment of Progenitor Cells in Cell Therapy" and is Guest Edited by Dr. Glenn Prestwich
Scope of Biomatter
Recent developments in medicine have resulted in a considerable and unprecedented increase in life span. The invention of artificial implants made from biomaterials, in the 1960s, created a whole new scientific field and resulted in revolutionary technologies that strongly contributed to this increase in life expectancy. Since then, many exciting advancements shaped the modern biomaterials science, which itself originated several new fields, with biology playing a major role and where the separation between engineering and health sciences can hardly be distinguishable. Current and future research efforts in this field are believed to result in new therapeutic approaches to prevent and treat debilitating and life-threatening diseases.
Biomatter covers all types of synthetic and natural biomaterials (metals, ceramics, polymers and composites) used for biomedical applications.
Note to Potential Authors
Biomatter accepts only manuscripts that have not been previously published nor currently submitted for publication elsewhere.
All manuscripts are peer-reviewed. The guidelines for authors, sample copies and other relevant information for submitting manuscripts are available on the Guidelines for Authors webpage.
Open access charges are waived until the July/August/September 2013 issue and the final version of accepted manuscripts will be posted on the website promptly. Authors will receive a free print version of the issue containing their paper. For additional information on how to submit your manuscript please visit our guidelines.
Biomatter appears as a forum to discuss and disclose the relevant advancements in the exciting and fast growing field of science and application of biomaterials. It is widely anticipated that current and future developments will soon result in products with potential to dramatically change the way in which we live, probably even with yet unimaginable future implications in healthcare.
Biomatter is an international and transdisciplinary journal for publication of peer-reviewed original research exploring the clinical and laboratory investigations in the field of science and application of biomaterials, including their physico-chemical and biological properties, as well as clinical performance, and especially those emphasizing the correlation between biomaterials structure and biological performance. The journal intends to cover all applications of biomaterials, including implantable medical devices, drug delivery systems, nanomedicine, tissue engineering and regenerative medicine.
Biomatter is intended to help researchers, academics, clinicians, industry professionals and policy makers, working in related fields of science, engineering and health sciences, to disseminate information associated to biomaterials and its related fields.